Ingenol mebutate (Picato) for actinic keratoses

Medical Letter on Drugs and Therapeutics

Volumn 54, Issue 1389, 2012, Pages 35-36

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CERAC; DICLOFENAC; FLUOROURACIL; IMIQUIMOD; INGENOL MEBUTATE; UNCLASSIFIED DRUG; 3 INGENYL ANGELATE; 3-INGENYL ANGELATE; DITERPENE;

ACTINIC KERATOSIS; BLISTER; BLUE LIGHT; DRUG CLEARANCE; DRUG COST; DRUG MECHANISM; DRUG METABOLISM; ERYTHEMA; EYE PAIN; HUMAN; LETTER; PERIORBITAL EDEMA; PHOTODYNAMIC THERAPY; PTOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SKIN PIGMENTATION; SKIN SWELLING; SKIN ULCER; ULCER; ARTICLE; CHEMISTRY; EUPHORBIA; GEL; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, CUTANEOUS; DITERPENES; EUPHORBIA; GELS; HUMANS; KERATOSIS, ACTINIC;

EID: 84862629182     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. RV Patel et al. An update on nonmelanoma skin cancer. J Clin Aesthet Dermatol 2011; 4:20.
2. CJ Ko. Actinic keratosis: facts and controversies. Clin Dermatol 2010; 28:249.
3. B Berman et al. Pharmacotherapy of actinic keratosis. Expert Opin Pharmacother 2009; 10:3015.
4. RH Rosen et al. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. J Am Acad Dermatol 2012; 66:486.
5. M Lebwohl et al. Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012; 366:1010.
6. Imiquimod (Aldara) for actinic keratoses. Med Lett Drugs Ther 2004; 46:42.